-
Associate. Our translational research focuses on drug target discovery and novel therapy development to treat ocular vascular diseases, including diabetic retinopathy, wet age-related macular degeneration
-
to Cancer Center members, and the Human Genome Sequencing Center, the Center for Drug Discovery, and the Therapeutic Innovation Center focusing on drug development are additional unique resources. The Center
-
, the identification of which could dramatically accelerate drug discovery. To identify these pathways, the postdoctoral fellow will use human iPSC-derived neurons and cutting-edge approaches, including single-cell RNA
-
are available to Cancer Center members, and the Human Genome Sequencing Center, the Center for Drug Discovery, and the Therapeutic Innovation Center focusing on drug development are additional unique resources
-
medicine and proteogenomics. Ten Shared Resources are available to Cancer Center members, and the Human Genome Sequencing Center, the Center for Drug Discovery, and the Therapeutic Innovation Center focusing
-
Genome Sequencing Center, the Center for Drug Discovery, and the Therapeutic Innovation Center focusing on drug development are additional unique resources. The Center is the recipient of a $100M naming
-
for Drug Discovery are additional unique resources. The Center is the recipient of a $100M naming gift from the Duncan family to be used largely for program development and recruitment. Minimum